About Fred Schwarzer
Fred Schwarzer is an executive officer, director and promoter at MultiValent Biotherapies.
Fred Schwarzer reports to the SEC as a director or officer of 1 public company: IGM Biosciences (IGMS).
Fred Schwarzer first appears on SEC filings in 2019.
Experience
This experience comes from Fred Schwarzer's profile and from SEC filings. For roles taken from filings, the years are when the filings name Fred Schwarzer in the role, so the role may have started earlier or lasted longer.
MultiValent Biotherapies, Inc. Current
Executive officer
Executive Chairman (2024 – Present)
2024 – Present · Los Altos, CA
Develops targeted drug therapies for people with cancer.
II
IGM Biosciences, Inc.
CEO and PRESIDENT, director
Chief Executive Officer (2010 – 2024)
2010 – 2024 · Public company (IGMS)
CS
Charter Life Sciences
Managing Partner
2003 – 2018
MC
Mingly Capital Corporation
President
2001 – 2003
CC
C.M. Capital Corporation
Senior Vice President
1999 – 2001
HC
Heska Corporation
Chairman Of The Board
1994 – 2001
Key Colleagues at Startups
The people Fred Schwarzer works with at each company, as listed on that company's latest Form D.
MultiValent Biotherapies, Inc. · Form D, Mar 2, 2026
SS
Stephen Snowdy
Executive officer, director and promoter
BK
Bruce Keyt
Executive officer, director and promoter
DS
Deborah Schwarzer
Chief Legal Officer and director